Association Between Histopathology And Magnetic Resonance Imaging Texture In Grading Gliomas Based On Intraoperative Magnetic Resonance Navigated Stereotactic Biopsy

Objective To explore the value of magnetic resonance imaging (MRI) textures and its correlation with histopathological malignancy of gliomas by magnetic resonance (MR) navigated stereotactic biopsy. Methods A total of 36 diffuse glioma cases and 64 puncture targets were included. All patients underwent a preoperative MR scan and intraoperative MR-navigated stereotactic biopsy. The histopathological diagnosis was grade II or grade III diffuse glioma. Regions of interest consistent with puncture targets were delineated on T1-weighted brain volume with gadolinium contrast enhancement images, and textures were extracted using Omni Kinetics software. Mann-Whitney rank sum test was used to analyze texture differences between grade II and grade III samples. False discovery rate (FDR) correction was applied to correct for multiple comparisons. Receiver operating characteristic curves evaluated the diagnostic value of textural analysis for grading gliomas. Correlation between MRI textures and histopathology was examined by Spearman correlation test. Results Texture features, including max intensity, 95th quantile, range, variance, standard deviation, sum variance, and cluster prominence were higher in grade III glioma targets than grade IIs, grade II gliomas showed increased uniformity and short run low gray-level emphasis values (P and qFDR(corr) < 0.05). Area under the curve was 0.887 (95% confidence interval, 0.805-0.969; P < 0.001) with combined textures in glioma grading. The listed first-order and gray-level cooccurrence matrix textures were correlated with Ki-67 labeling index. Gray-level cooccurrence matrix and gray-level run length matrix textures were correlated with isocitrate dehydrogenase 1 mutation. Conclusions Textures on T1-weighted brain volume with gadolinium contrast enhancement images differ between grade III and II gliomas and are correlated with Ki-67 labeling index and isocitrate dehydrogenase 1 mutation.